Organon Bolsters Research & Development Expertise with Two Leadership Appointments

Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced the appointment of Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owens, M.D., as Head of Medical Affairs and Outcomes Research.

With Covid sales declining, Pfizer zeroes in on M&A and oncology

Roughly a month after announcing plans to merge several units under Sumitomo Pharma America this July, the drugmaker is making cuts in Massachusetts. Sumitomo Pharma

May 3, 2023

Mediterranean diet linked to improved sperm quality

A study in the journal Nutrients finds that adherence to the Mediterranean diet positively correlates with improved sperm parameters in men. This observational cross-sectional study,

December 6, 2023

Journal of Pediatric Rehabilitation Medicine publishes supplement on spina bifida research and care

A supplement to the Journal of Pediatric Rehabilitation Medicine (JPRM) published by IOS Press, presents a compendium of abstracts from the 2023 World Congress on

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.